These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15115128)

  • 41. [Type 2B and pseudo type 2B Von Willebrand disease; a report of three cases].
    Guermazi S; Conard J; Samama MM; Dellagi K
    Pathol Biol (Paris); 2006 Apr; 54(3):159-65. PubMed ID: 16176858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombocytopenia in dengue fever.
    Schexneider KI; Reedy EA
    Curr Hematol Rep; 2005 Mar; 4(2):145-8. PubMed ID: 15720964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in clinical and laboratory characteristics and disease severity between children and adults with dengue virus infection in Taiwan, 2002.
    Wang CC; Lee IK; Su MC; Lin HI; Huang YC; Liu SF; Wu CC; Lin MC
    Trans R Soc Trop Med Hyg; 2009 Sep; 103(9):871-7. PubMed ID: 19500813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hepatic alterations in patients with dengue].
    Larreal Y; Valero N; Estévez J; Reyes I; Maldonado M; Espina LM; Arias J; Meleán E; Añez G; Atencio R
    Invest Clin; 2005 Jun; 46(2):169-78. PubMed ID: 16001748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Severe dengue virus infection in travelers: risk factors and laboratory indicators.
    Wichmann O; Gascon J; Schunk M; Puente S; Siikamaki H; Gjørup I; Lopez-Velez R; Clerinx J; Peyerl-Hoffmann G; Sundøy A; Genton B; Kern P; Calleri G; de Górgolas M; Mühlberger N; Jelinek T;
    J Infect Dis; 2007 Apr; 195(8):1089-96. PubMed ID: 17357044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between circulating vascular endothelial growth factor and its soluble receptors in adults with dengue virus infection: a case-control study.
    Seet RC; Chow AW; Quek AM; Chan YH; Lim EC
    Int J Infect Dis; 2009 Sep; 13(5):e248-53. PubMed ID: 19261502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection.
    Noisakran S; Perng GC
    Exp Biol Med (Maywood); 2008 Apr; 233(4):401-8. PubMed ID: 18367628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of efficacy of high-dose intravenous immunoglobulin treatment of severe thrombocytopenia in patients with secondary dengue virus infection.
    Dimaano EM; Saito M; Honda S; Miranda EA; Alonzo MT; Valerio MD; Mapua CA; Inoue S; Kumaori A; Matias R; Natividad FF; Oishi K
    Am J Trop Med Hyg; 2007 Dec; 77(6):1135-8. PubMed ID: 18165536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MBL2 gene polymorphisms protect against development of thrombocytopenia associated with severe dengue phenotype.
    Acioli-Santos B; Segat L; Dhalia R; Brito CA; Braga-Neto UM; Marques ET; Crovella S
    Hum Immunol; 2008 Feb; 69(2):122-8. PubMed ID: 18361938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13.
    Djamiatun K; van der Ven AJ; de Groot PG; Faradz SM; Hapsari D; Dolmans WM; Sebastian S; Fijnheer R; de Mast Q
    PLoS Negl Trop Dis; 2012; 6(5):e1628. PubMed ID: 22563509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on dengue and dengue haemorrhagic fever (DHF) in West Bengal State, India.
    Hati AK
    J Commun Dis; 2006 Mar; 38(2):124-9. PubMed ID: 17370674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia.
    Wang ZJ; Onwuzurike N; Callaghan MU; Rajpurkar M; Chitlur M; Lusher JM
    Pediatr Blood Cancer; 2008 Sep; 51(3):416-8. PubMed ID: 18493997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.
    De Meyer SF; Vandeputte N; Pareyn I; Petrus I; Lenting PJ; Chuah MK; VandenDriessche T; Deckmyn H; Vanhoorelbeke K
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1621-6. PubMed ID: 18556568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dengue virus and endothelial cell: a related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever.
    Butthep P; Bunyaratvej A; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():246-9. PubMed ID: 7886587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
    Lethagen S; Hillarp A; Ekholm C; Mattson E; Halldén C; Friberg B
    Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of IgM anti-platelet autoantibody in dengue patients.
    Lin CF; Lei HY; Liu CC; Liu HS; Yeh TM; Wang ST; Yang TI; Sheu FC; Kuo CF; Lin YS
    J Med Virol; 2001 Feb; 63(2):143-9. PubMed ID: 11170051
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transfusion support to Dengue patients in a hospital based blood transfusion service in north India.
    Chaudhary R; Khetan D; Sinha S; Sinha P; Sonker A; Pandey P; Das SS; Agarwal P; Ray V
    Transfus Apher Sci; 2006 Dec; 35(3):239-44. PubMed ID: 17097349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Predictive factors of dengue shock syndrome at the children Hospital No. 1, Ho-chi-Minh City, Vietnam].
    Pham TB; Nguyen TH; Vu TQ; Nguyen TL; Malvy D
    Bull Soc Pathol Exot; 2007 Feb; 100(1):43-7. PubMed ID: 17402695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections.
    Libraty DH; Endy TP; Houng HS; Green S; Kalayanarooj S; Suntayakorn S; Chansiriwongs W; Vaughn DW; Nisalak A; Ennis FA; Rothman AL
    J Infect Dis; 2002 May; 185(9):1213-21. PubMed ID: 12001037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.